Reliq Health Technologies Inc. (RHT:TSX.V; RQHTF:OTCQB) signed six new clients, it announced in a news release.
These new healthcare customers, located in California, Montana and Texas, are an employer-sponsored health plan, a congestive heart failure management service, home health agencies and adult medical care day centers.
Reliq Health is a technology company that develops mobile health and telemedicine solutions for the community care market. "Reliq's powerful iUGO CARE platform supports care coordination and community-based healthcare. iUGO CARE allows complex patients to receive high quality care at home and in the community setting, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO CARE provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits," the company stated.
"It is gratifying to see the private payers following the precedent set by the Centers for Medicare and Medicaid Services in providing reimbursement for remote patient monitoring RPM)," Reliq CEO Dr. Lisa Crossley said in the release. "There is clear evidence that implementing an RPM program for chronic disease patients significantly reduces preventable complications, resulting in fewer ER visits and hospital stays, lower healthcare costs and a better quality of life for these patients and their loved ones. It is incredibly motivating for the Reliq team to see the real impact our technology has on patients' health and happiness."
[NLINSERT]Disclosure:
1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this interview, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Reliq Health Technologies, a company mentioned in this article.
